Pharmacologic Substance
nadroparin
Effect:
Decreased Coagulation Factor Activity
May Prevent:
Angina, Unstable; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Venous Thrombosis
May Treat:
Angina, Unstable;
Myocardial Infarction;
Postoperative Complications;
Pulmonary Embolism;
Thromboembolism
Definitions related to nadroparin:
-
A heparin fraction with a mean molecular weight of 4500 daltons. It is isolated from porcine mucosal heparin and used as an antithrombotic agent. (From Merck Index, 11th ed)NLM Medical Subject HeadingsU.S. National Library of Medicine, 2021
-
(nadroparin calcium) A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot.NCI ThesaurusU.S. National Cancer Institute, 2021
Return to OpenMD Medical Dictionary
> N
This content should not be used in place of medically-reviewed decision support reference material or professional medical advice. Some terms may have alternate or updated definitions not reflected in this set. The definitions on this page should not be considered complete or up to date.